FilingSEC EDGAR8-K
TScan Therapeutics Enters into Separation Agreements with Departing Executives
· SEC accepted
StageExecutive Departure
Filing content
The company entered into separation agreements with its departing CFO and CMO as part of a strategic reorganization, including conditional lump-sum payments of $85,000 and $125,000 upon achievement of certain milestones.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…